文献速递创伤与烧伤重症综合管理与镇静镇痛复苏、休克与脓毒症

每日给予普萘洛尔可减轻严重创伤及慢性应激后的持续性损伤相关贫血

Daily propranolol administration reduces persistent injury-associated anemia after severe trauma and chronic stress.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论大鼠肺挫伤+失血性休克+慢性应激模型中,每日普萘洛尔10 mg/kg使第7天血红蛋白从10.6±0.8升至13.9±0.4 g/dL,并恢复骨髓功能与铁稳态。

研究采用肺挫伤(LC)、失血性休克(HS)和慢性应激(CS)的大鼠模型,探讨每日给予非选择性β受体阻滞剂普萘洛尔(BB,10 mg/kg)对持续性损伤相关贫血的影响。结果显示,在LCHS基础上加入CS导致第7天持续性贫血,而每日BB使血红蛋白从10.6±0.8 g/dL升至13.9±0.4 g/dL,并改善骨髓细胞数及红系集落生长。BB还显著降低血浆促红细胞生成素(EPO)水平并升高血浆铁调素(hepcidin)水平。CS导致肝脏膜铁转运蛋白(ferroportin)及骨髓转铁蛋白(transferrin)、转铁蛋白受体-1(TFR-1)表达下降,而每日BB改善了所有这些铁调节因子的表达。作者结论认为,LCHS/CS后每日给予普萘洛尔可恢复骨髓功能、改善贫血及铁稳态。

要点

  • 在肺挫伤+失血性休克+慢性应激大鼠模型中,每日普萘洛尔10 mg/kg使第7天血红蛋白从10.6±0.8 g/dL升至13.9±0.4 g/dL(p<0.05)。
  • 每日普萘洛尔改善LCHS/CS后骨髓细胞数及粒细胞-红细胞-单核细胞-巨核细胞集落形成单位、红系爆式集落形成单位和红系集落形成单位的生长。
  • LCHS/CS+BB组第7天血浆EPO水平显著降低、血浆铁调素水平升高。
  • CS导致肝脏ferroportin及骨髓transferrin、TFR-1表达下降,每日BB改善所有这些铁调节因子的表达。
  • 该研究为啮齿类动物模型,普萘洛尔10 mg/kg每日给药方案为实验方案,非临床推荐剂量。

适用人群与场景

  • 雄性Sprague-Dawley大鼠,接受肺挫伤(LC)、失血性休克(HS)±慢性应激(CS)模型。

处置流程与药物剂量

  • 普萘洛尔(非选择性β受体阻滞剂)10 mg/kg每日给药,直至处死日;为动物实验方案。
  • 评估指标包括血红蛋白、血浆EPO、血浆铁调素、骨髓细胞数及骨髓红系集落生长,以及transferrin、TFR-1和ferroportin的RNA表达。

研究设计与关键结果

  • 研究类型:啮齿类动物实验;样本:雄性Sprague-Dawley大鼠;分组:LCHS±BB、LCHS/CS±BB。
  • 主要结果:LCHS/CS组第7天血红蛋白10.6±0.8 g/dL vs LCHS/CS+BB组13.9±0.4 g/dL,BB组升高(p<0.05)。
  • 每日BB改善LCHS/CS后骨髓细胞数、CFU-GEMM、BFU-E和CFU-E集落生长。
  • LCHS/CS+BB组第7天血浆EPO水平显著降低,血浆铁调素水平升高。
  • CS导致肝脏ferroportin及骨髓transferrin、TFR-1表达下降;每日BB改善所有铁调节因子表达。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,LCHS/CS后每日给予普萘洛尔可恢复骨髓功能并改善严重创伤后贫血。
  • 作者认为,LCHS/CS后铁调节因子显著降低,可能造成损伤后铁限制;每日普萘洛尔改善铁稳态。
  • 普萘洛尔10 mg/kg每日方案为大鼠实验方案,不能直接作为临床剂量推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: After severe trauma, patients develop a norepinephrine-mediated persistent, injury-associated anemia. This anemia is associated with suppression of bone marrow (BM) erythroid colony growth, along with decreased iron levels, and elevated erythropoietin (EPO) levels, which are insufficient to promote effective erythropoiesis. The impact of norepinephrine on iron regulators, such as ferroportin, transferrin, and transferrin receptor-1 (TFR-1), is unknown. Using a clinically relevant rodent model of lung contusion (LC), hemorrhagic shock (HS), and chronic stress (CS), we hypothesize that daily propranolol (BB), a nonselective β blocker, restores BM function and improves iron homeostasis.

METHODS: Male Sprague-Dawley rats were subjected to LCHS ± BB and LCHS/CS ± BB. BB was achieved with propranolol (10 mg/kg) daily until the day of sacrifice. Hemoglobin, plasma EPO, plasma hepcidin, BM cellularity and BM erythroid colony growth were assessed. RNA was isolated to measure transferrin, TFR-1 and ferroportin expression. Data are presented as mean ± SD; *p < 0.05 versus untreated counterpart by t test.

RESULTS: The addition of CS to LCHS leads to persistent anemia on posttrauma day 7, while the addition of BB improved hemoglobin levels (LCHS/CS: 10.6 ± 0.8 vs. LCHS/CS + BB: 13.9 ± 0.4* g/dL). Daily BB use after LCHS/CS improved BM cellularity, colony-forming units granulocyte, erythrocyte, monocyte megakaryocyte, burst-forming unit erythroid and colony-forming unit erythroid cell colony growth. LCHS/CS + BB significantly reduced plasma EPO levels and increased plasma hepcidin levels on day 7. The addition of CS to LCHS resulted in decreased liver ferroportin expression as well as decreased BM transferrin and TFR-1 expression, thus, blocking iron supply to erythroid cells. However, daily BB after LCHS/CS improved expression of all iron regulators.

CONCLUSION: Daily propranolol administration after LCHS/CS restored BM function and improved anemia after severe trauma. In addition, iron regulators are significantly reduced after LCHS/CS, which may contribute to iron restriction after injury. However, daily propranolol administration after LCHS/CS improved iron homeostasis.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Alamo IG, Kannan KB, Bible LE, et al. Daily propranolol administration reduces persistent injury-associated anemia after severe trauma and chronic stress. J Trauma Acute Care Surg. 2017. PMID: 28099381. doi:10.1097/TA.0000000000001374

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。